P-LLY PP-ZP-US-0986 08/2024 Lilly Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995), including statements about the supply and access of Zepbound (tirzepatide) as a treatment for adults with obesity or overweight and reflects Lilly's current belief and expectations
General Dosing Information: The dosage of sermorelin must be individualized based on the patients age, weight (particularly in pediatric patients), and the condition being treated
Overall, GLP-1 therapies may offer a useful option for certain patients with PCOS, especially when metabolic dysfunction is a central feature
Lip Augmentation | Fat Transfer synergizes well with facelift, brow lift, upper and lower blepharoplasty, neck lift, and overall facial fat grafting
IGF-1, sleep quality, recovery, and body composition are tracked across each cycle